AVAH Aveanna Healthcare Holdings, Inc.
Services-Home Health Care Services · Nasdaq · SEC CIK 1832332 · Fiscal year ends 01/01
Financial factors as of 2026-10-03 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY16.8%
TTM net income YoY305.7%
TTM EPS YoY278.4%
Revenue 3-yr CAGR12.7%
Net income 3-yr CAGR—
Margins
Gross margin32.3%
Operating margin11.4%
Net margin11.4%
FCF margin—
EBITDA margin11.8%
Returns
ROE176.7%
ROA15.2%
ROIC (approx.)23.4%
Asset turnover1.33x
Leverage & solvency
Liabilities / assets84.7%
Debt / equity3.84x
Current ratio1.23x
Interest coverage2.61x
Cash quality & payout
Operating cash flow / net income0.68x
Accruals ratio4.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-01-03 | FY20242024-12-28 |
|---|---|---|
| Income statement | ||
| Revenue | $2.43B | $2.02B |
| Cost of revenue | $1.62B | $1.39B |
| Gross profit | $810.48M | $635.54M |
| SG&A expense | $374.50M | $352.81M |
| Operating income | $256.46M | $139.79M |
| Interest expense | $140.09M | $156.60M |
| Pretax income | $106.95M | $5.07M |
| Income tax | -$118.09M | $16.00M |
| Net income | $225.03M | -$10.93M |
| EBITDA | $267.00M | $150.56M |
| EPS (basic) | 1.11 | -0.06 |
| EPS (diluted) | 1.05 | -0.06 |
| Weighted avg. shares (diluted) | 214.98M | 192.89M |
| Balance sheet | ||
| Cash & equivalents | $193.26M | $84.29M |
| Receivables | $313.36M | $265.19M |
| Current assets | $560.23M | $392.67M |
| PP&E, net | $16.65M | $17.37M |
| Goodwill | $1.12B | $1.05B |
| Intangibles | $92.56M | $89.57M |
| Total assets | $2.01B | $1.66B |
| Current liabilities | $424.46M | $402.17M |
| Short-term debt | $13.25M | $9.20M |
| Long-term debt | $1.29B | $1.27B |
| Total debt | $1.30B | $1.28B |
| Total liabilities | $1.82B | $1.79B |
| Shareholders' equity | $194.46M | -$123.55M |
| Net debt | $1.11B | $1.20B |
| Shares outstanding | 211.00M | 193.23M |
| Cash flow statement | ||
| Operating cash flow | $125.86M | $32.64M |
| Investing cash flow | -$22.30M | -$6.32M |
| Financing cash flow | $5.41M | $14.03M |
| Depreciation & amortization | $10.54M | $10.78M |
| Stock-based compensation | $25.06M | $17.46M |
Free plan shows the latest 2 periods; Pro shows all 7 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.